US life expectancy drops for second year thanks to COVID-19, drug overdoses: CDC
By
Kimberly Bonvissuto
Jan 03, 2023
Life expectancy in the United States fell for a second consecutive year due to COVID-19 deaths and drug overdoses, falling to the shortest lifespan since 1996, according to a recent report from the Centers...
Big senior living stories of 2022
By
Lois A. Bowers
Dec 22, 2022
Here are some of the major stories that affected senior living providers in 2022.
Rebound emerging in senior living
By
John Lariccia
Dec 22, 2022
With the right technology, deployed in the right way, senior living operators can benefit from the rebound emerging.
‘Tripledemic’ is hurting census growth: NIC
By
Kimberly Bonvissuto
Dec 19, 2022
The pace of move-ins in senior housing and care organizations continued to hold steady, but a “triplememic” of viral respiratory infections is creating a disconnect between move-in rates and higher...
Survey reveals list of must-haves for potential CCRC residents
By
Kimberly Bonvissuto
Dec 19, 2022
Continuing care retirement community operators considering near- and mid-term investments, amenities and programming should look to ensure healthy aging offerings are in the mix, according to a new survey...
Senior housing total investment return rises again in Q3: NIC
By
Kathleen Steele Gaivin
Dec 15, 2022
The senior living sector has seen nine consecutive quarters of total investment return gains since the second quarter of this year, according to a National Investment Center for Seniors Housing & Care...
Senior living leaders named to ‘top lobbyists’ list
By
Kimberly Bonvissuto
Dec 08, 2022
Representatives from trade associations representing the senior living field have been named to The Hill’s ‘Top Lobbyists 2022” list, published Wednesday.
LeadingAge Minnesota Foundation invests $400,000 in 24 workforce grants
By
Kathleen Steele Gaivin
Dec 06, 2022
The LeadingAge Minnesota Foundation has announced $400,000 in grants to support the senior living and care workforce.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Aloha State’s healthcare workforce need grows 76 percent since 2019: report
By
Kimberly Bonvissuto
Nov 21, 2022
What difference can three years and a once-in-a-century pandemic make to Hawaii’s healthcare workforce?